Cargando…

Monoclonal Antibodies for Chronic Pain Treatment: Present and Future

Chronic pain remains a major problem worldwide, despite the availability of various non-pharmacological and pharmacological treatment options. Therefore, new analgesics with novel mechanisms of action are needed. Monoclonal antibodies (mAbs) are directed against specific, targeted molecules involved...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sánchez-Robles, Eva M., Girón, Rocío, Paniagua, Nancy, Rodríguez-Rivera, Carmen, Pascual, David, Goicoechea, Carlos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508878/ https://www.ncbi.nlm.nih.gov/pubmed/34638667 http://dx.doi.org/10.3390/ijms221910325

Ejemplares similares

Monoclonal Antibodies in Multiple Sclerosis: Present and Future
por: Voge, Natalia V., et al.
Publicado: (2019)

Monoclonal antibodies for chronic pain: A practical review of mechanisms and clinical applications
por: Yeh, Ju-Fen, et al.
Publicado: (2017)

Past, Present, and Future of Rituximab—The World’s First Oncology Monoclonal Antibody Therapy
por: Pierpont, Timothy M., et al.
Publicado: (2018)

The past, present, and future of monoclonal antibodies to IL-5 and eosinophilic asthma: a review
por: Patterson, Megan F, et al.
Publicado: (2015)

Future of Monoclonal Antibody Therapy in Parkinson’s Disease
por: Kharel, Sanjeev, et al.
Publicado: (2022)

Development of Vasoinhibin-Specific Monoclonal Antibodies
por: Müller, Nils, et al.
Publicado: (2021)

Safety of anti-CGRP monoclonal antibodies in patients with migraine during the COVID-19 pandemic: Present and future implications
por: Caronna, E., et al.
Publicado: (2021)

Safety of anti-CGRP monoclonal antibodies in patients with migraine during the COVID-19 pandemic: Present and future implications
por: Caronna, E., et al.
Publicado: (2021)

Acute low back pain as infusion-related reaction to monoclonal antibodies
por: Majenka, Pawel, et al.
Publicado: (2023)

Customer-centric product presentations for monoclonal antibodies
por: Bittner, Beate
Publicado: (2023)

Monoclonal Antibodies in Dermatooncology—State of the Art and Future Perspectives
por: Bobrowicz, Malgorzata, et al.
Publicado: (2019)

Tanezumab: Finally a Monoclonal Antibody for Pain Relief
por: Nair, Abhijit S
Publicado: (2018)

Monoclonal antibodies as anti-infective products: a promising future?
por: Pelfrene, E., et al.
Publicado: (2019)

Human monoclonal antibodies and monoclonal antibody multispecificity.
por: Campbell, A. M., et al.
Publicado: (1987)

The Role of Anti-Nerve Growth Factor Monoclonal Antibodies in the Control of Chronic Cancer and Non-Cancer Pain
por: Bimonte, Sabrina, et al.
Publicado: (2021)

Anti-CTLA4 monoclonal antibodies: the past and the future in clinical application
por: Ascierto, Paolo A, et al.
Publicado: (2011)

Treating Alzheimer’s disease with monoclonal antibodies: current status and outlook for the future
por: Prins, Niels D, et al.
Publicado: (2013)

Monoclonal antibodies in the treatment of multiple myeloma: current status and future perspectives
por: Lonial, S, et al.
Publicado: (2016)

The history of monoclonal antibody development – Progress, remaining challenges and future innovations
por: Liu, Justin K.H.
Publicado: (2014)

Current and Future Applications of Monoclonal Antibodies against Bacteria in Veterinary Medicine
por: SHERMAN, DAVID M., et al.
Publicado: (1986)

Blockade of sigma 1 receptors alleviates sensory signs of diabetic neuropathy in rats
por: Paniagua, N., et al.
Publicado: (2016)

Therapeutic Application of Monoclonal Antibodies in Pancreatic Cancer: Advances, Challenges and Future Opportunities
por: Arias-Pinilla, Gustavo A., et al.
Publicado: (2021)

Monoclonal Antibodies for Protozoan Infections: A Future Reality or a Utopic Idea?
por: Longoni, Silvia Stefania, et al.
Publicado: (2021)

Monoclonal antibodies in the management of asthma: Dead ends, current status and future perspectives
por: Kardas, Grzegorz, et al.
Publicado: (2022)

281 Use of Monoclonal Antibody Omalizumab in the Treatment of Urticaria Chronic
por: Correa, Jorge Vargas
Publicado: (2012)

Therapeutic Monoclonal Antibody Therapies in Chronic Autoimmune Demyelinating Neuropathies
por: Briani, Chiara, et al.
Publicado: (2022)

CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients
por: Schiano di Cola, Francesca, et al.
Publicado: (2022)

Antibody-drug conjugates: Present and future
por: Beck, Alain, et al.
Publicado: (2013)

Monoclonal Antibodies in Cancer
por: Ghosh, A.K.
Publicado: (1986)

Pharmacokinetics of Monoclonal Antibodies
por: Ryman, Josiah T., et al.
Publicado: (2017)

In vitro affinity optimization of an anti-BDNF monoclonal antibody translates to improved potency in targeting chronic pain states in vivo
por: Stack, Edwina, et al.
Publicado: (2020)

Nociplastic Pain Criteria or Recognition of Central Sensitization? Pain Phenotyping in the Past, Present and Future
por: Nijs, Jo, et al.
Publicado: (2021)

A fully caninised anti-NGF monoclonal antibody for pain relief in dogs
por: Gearing, David P, et al.
Publicado: (2013)

Anti-nerve growth factor monoclonal antibodies for the control of pain in dogs and cats
por: Enomoto, Masataka, et al.
Publicado: (2019)

Possible Future Monoclonal Antibody (mAb)-Based Therapy against Arbovirus Infections
por: Sautto, Giuseppe, et al.
Publicado: (2013)

Monoclonal Antibodies against SARS-CoV-2: Current Scenario and Future Perspectives
por: Quiros-Roldan, Eugenia, et al.
Publicado: (2021)

Monoclonal antibody therapies for COVID-19: lessons learned and implications for the development of future products()
por: Kelley, Brian, et al.
Publicado: (2022)

The Use of Monoclonal Antibodies in the Treatment of Autoimmune Complications of Chronic Lymphocytic Leukemia
por: Laurenti, Luca, et al.
Publicado: (2013)

“Triaging” Chronic Migraine Patients in Need of CGRP(r) Monoclonal Antibodies
por: Martelletti, Paolo
Publicado: (2020)

An Overview of the Safety and Efficacy of Monoclonal Antibodies for the Chronic Obstructive Pulmonary Disease
por: Cazzola, Mario, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_in91mdscg769eu3h3l7vj5ivci